default author photo

Paul Goepfert

University of Alabama at Birmingham - Heersink School of Medicine

SCHOLARLY PAPERS

4

DOWNLOADS

353

TOTAL CITATIONS

0

Scholarly Papers (4)

1.

Risk of COVID-19 after Natural Infection or Vaccination

Number of pages: 24 Posted: 01 May 2023
University of Pittsburgh - Department of Pediatrics, University of Maryland, Baltimore (UMB) - School of Medicine, Fred Hutchinson Cancer Research Center, affiliation not provided to SSRN, Fred Hutchinson Cancer Research Center, University of California, San Diego (UCSD) - Division of Infectious Diseases and Global Public Health, University of South Florida - Morsani College of Medicine, Emory University School of Medicine and Children’s Healthcare of Atlanta - Department of Pediatrics, Ndlovu Research Centre, Harvard University - Brigham and Women’s Hospital, Baylor College of Medicine, Instituto Nacional de Infectologia Evandro Chagas, Fiocruz - Lab. De Pesquisa Clinica DST/AIDS, South African Medical Research Council, University of North Carolina (UNC) at Chapel Hill - School of Medicine, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Moderna, Inc., AstraZeneca Pharmaceuticals, Janssen Research & Development, LLC, Novavax, Inc., - Center for Vaccine Development and Global Health, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, University of Alabama at Birmingham - Heersink School of Medicine, Harvard University - Brigham and Women’s Hospital, Government of the United States of America - Biostatistics Research Branch and - Department of Pediatrics
Downloads 228 (334,744)

Abstract:

Loading...

COVID-19, natural infection, hybrid immunity, vaccination

2.

Baseline Host Determinants of Robust Human HIV-1 Vaccine- Induced Immune Responses: A Meta-Analysis of 26 Vaccine Regimens

Number of pages: 43 Posted: 11 Apr 2022
Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Duke University, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, University of KwaZulu-Natal - Centre for the AIDS Programme of Research in South Africa, University of Manitoba, Instituto Nacional de Saude, South African Medical Research Council, Aurum Institute, University of California, San Francisco (UCSF) - Department of Epidemiology and Biostatistics, Emory University - School of Medicine, University of Cape Town (UCT) - Desmond Tutu HIV Centre, University of Rochester - School of Medicine and Dentistry, University of North Carolina (UNC) at Chapel Hill - UNC-Project Malawi, University of Alabama at Birmingham - Heersink School of Medicine, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, University of Rochester - School of Medicine and Dentistry, University of Alabama at Birmingham, Fenway Community Health - The Fenway Institute, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Independent and affiliation not provided to SSRN
Downloads 76 (830,555)

Abstract:

Loading...

Baseline characteristics, SuperLearner, Variable importance measurements, Vaccine response heterogeneity, Antibody, CD4+ T cell

3.

Convalescent Plasma-Mediated Resolution of Covid-19 in Humoral Immunodeficiency

Number of pages: 29 Posted: 05 Sep 2020
Department of Medicine, University of Alabama at Birmingham, University of Pennsylvania - Department of Medicine, Department of Medicine, University of Alabama at Birmingham, Department of Medicine, University of Pennsylvania, Department of Medicine, University of Pennsylvania, Department of Medicine, University of Alabama at Birmingham, University of Alabama at Birmingham - Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Department of Pathology, University of Alabama at Birmingham, Department of Medicine, University of Alabama at Birmingham, Department of Pathology, University of Alabama at Birmingham, Department of Pathology, University of Alabama at Birmingham, LifeSouth Community Blood Centers, Department of Medicine, University of Alabama at Birmingham, Department of Microbiology and Immunology, Weill Medical College of Cornell University, Rockefeller University - Laboratory of Retrovirology, Rockefeller University - Laboratory of Retrovirology, Department of Biostatistics, University of Alabama at Birmingham, Department of Microbiology and Immunology, Weill Medical College of Cornell University, University of Alabama at Birmingham - Heersink School of Medicine, University of Alabama at Birmingham - Department of Medicine, University of Pennsylvania - Departments of Medicine and Microbiology and University of Alabama at Birmingham - School of Medicine
Downloads 27 (1,359,097)

Abstract:

Loading...

immunodeficiency, SARS-CoV-2, COVID-19, convalescent plasma, neutralizing antibodies

4.

Impact of prior SARS-CoV-2 acquisition on binding and neutralizing antibody responses following COVID-19 vaccination: A cross-protocol analysis of individual-level data from six phase 3 clinical trials

Number of pages: 30 Posted: 10 Jan 2026
Fred Hutchinson Cancer Research Center, University of Illinois Chicago, University of Pittsburgh - Department of Pediatrics, University of Maryland, Baltimore (UMB) - School of Medicine, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, University of North Carolina (UNC) at Chapel Hill - School of Medicine, Harvard University - Brigham and Women’s Hospital, University of Alabama at Birmingham - Heersink School of Medicine, Emory University, Baylor College of Medicine, South African Medical Research Council, Instituto Nacional de Infectologia Evandro Chagas, Fiocruz - Lab. De Pesquisa Clinica DST/AIDS, Columbia University - Aaron Diamond AIDS Research Center, University of Rochester, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Government of the United States of America - Biostatistics Research Branch, National Institutes of Health - Vaccine Research Center, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Novavax, Inc., Sanofi - Pennsylvania, affiliation not provided to SSRN, - Center for Vaccine Development and Global Health, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Harvard University - Brigham and Women’s Hospital, - Department of Pediatrics and Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division
Downloads 22 (1,436,435)

Abstract:

Loading...

(3-10): COVID-19, SARS-CoV-2, antibody, Vaccination, immunity, natural immunity, hybrid immunity, correlate of protection, Efficacy